Results 181 to 190 of about 36,199 (325)

Autism and Measles‐Mumps‐Rubella (MMR) Vaccination: A Challenge for Pharmacoepidemiology [PDF]

, 2003
D C Skegg
openalex   +1 more source

Association of Receipt of Opioid Prescription for Acute Post-Delivery Pain Management with Buprenorphine Discontinuation among Postpartum People with Opioid Use Disorder

Pharmacoepidemiology
Buprenorphine is a safe and effective medication to treat opioid use disorder (OUD) in pregnant patients and is intended to be continued throughout pregnancy, delivery, and at least the one-year postpartum period.
Taylor N. Hallet, David T. Zhu, Hannah Shadowen, Lillia Thumma, Madison M. Marcus, Amy Salisbury, Caitlin E. Martin   +6 more
doaj   +1 more source

Engaging pharmacy students in research and course coordination through a clinical research design elective

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 8, Issue 6, Page 451-462, June 2025.
Abstract Introduction Despite accreditation standards requirements, structured research training is generally lacking in most Doctor of Pharmacy (Pharm.D.) programs. Studies demonstrate that participation in high‐quality research experiences increases learners' interest and engagement in lifelong scholarship.
Robert J. DiDomenico, Melissa E. Badowski, Nancy L. Shapiro, James Ning, Michelle Lee, Wesley J. Wong   +5 more
wiley   +1 more source

Real‐life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety

JEADV Clinical Practice, Volume 4, Issue 2, Page 416-424, June 2025.
Abstract Background Dupilumab, inhibiting interleukin 4 and 13, is the first monoclonal antibody licensed for atopic dermatitis (AD) since 6 months of age. Objectives The study describes the patients' profile, the effectiveness and safety in real life of dupilumab in adolescents with moderate‐severe AD and children with severe AD.
Eulalia Baselga Torres, Marta Ivars, Carolina Prat, Asunción Vicente, Marta Feito Rodríguez, Rocío Maseda Pedrero, Ana Martín Santiago, Aniza Giacaman, Antonio Torrelo Fernández, Lucero Noguera‐Morel, Isabel Betlloch Mas, Laura de Berbegal Gracia, Montserrat Évole Buselli, Mónica Pozuelo Ruiz, José Bernabéu Wittel, María T. Monserrat García, Minia Campos Domínguez, Cristina Galache Osuna, Jorge Santos‐Juanes Jiménez, Altea Esteve Martínez, Violeta Zaragoza Ninet, Miquel Casals Andreu, Sara I. Palencia Pérez, José Suárez Hernández, Sara Dorta Alom, Laura Feliciano Divasson, Ana Batalla Cebey, Manuel Galán Gutiérrez, Raúl de Lucas Laguna   +28 more
wiley   +1 more source

CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology

Neuropharmacology, 2022
Paul J. Harrison, S. M. Husain, Hami Lee, A. Angeles, Lucy Colbourne, Arne W. Mould, N. Hall, W. Haerty, E. Tunbridge   +8 more
semanticscholar   +1 more source

Research in pharmacoepidemiology in Iceland [PDF]

, 2012
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open Allur texti - Full textPharmacoepidemiology is a rapidly growing discipline that is useful in studies on effects and adverse effects of drugs.
Magnús Jóhannsson, Sigríður Haraldsdóttir,   +1 more
core  

Determining Drug Exposure Based on Medication Dispensing Data: A Validation Study of Vitamin K Antagonist Treatment Episodes Against INR Records

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 6, June 2025.
ABSTRACT Background In pharmaco‐epidemiological studies using vitamin K antagonist (VKA) exposure, constructing treatment episodes based on dispensed prescriptions is challenging, particularly due to the large variability in therapeutic dose.
Eva K. Kempers, Chantal Visser, Jamilla Goedegebuur, Qingui Chen, Mette Søgaard, Anne Gulbech Ording, Carline van den Dries, Denise Abbel, Sarah J. Aldridge, Kate J. Lifford, Johanneke E. A. Portielje, Melchior C. Nierman, Annelies Boetes‐Draisma, Sjef J. C. M. van de Leur, Frederikus A. Klok, Eric C. T. Geijteman, Marieke J. H. A. Kruip, Suzanne C. Cannegieter   +17 more
wiley   +1 more source

Using Quality of Life Measurements in Pharmacoepidemiology Research

, 2000
Gordon Guyatt, Roman Jaeschke
openalex   +1 more source

Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology [PDF]

, 2005
Peter Joseph Benedict Helms, Suzie Ekins Daukes, Michael W. Taylor, Colin R Simpson, James S. McLay   +4 more
openalex   +1 more source

Estimation of the Duration of Antihypertensive Prescriptions: Validation of a Data‐Driven Approach Using Rotterdam Study Data

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 6, June 2025.
ABSTRACT Objectives Administrative medicine dispensing data often omit prescribed duration, which is important for research on adherence or other pharmacoepidemiological topics. While the reverse waiting time distribution (rWTD) method has been widely used to estimate prescribed durations, its accuracy in real‐world dispensing data is unknown.
Chau L. B. Ho, David Youens, Walter P. Abhayaratna, Max K. Bulsara, Jeff Hughes, Rachael Moorin, Sallie‐Anne Pearson, David B. Preen, Christopher M. Reid, Rikje Ruiter, Christobel M. Saunders, Bruno H. Stricker, John Stubbs, Frank J. A. van Rooij, Cameron Wright, Ninh Thi Ha   +15 more
wiley   +1 more source